Breakdown | Dec 2024 | Dec 2023 | Dec 2022 |
---|---|---|---|
Income Statement | |||
Total Revenue | 6.56M | 13.20M | 22.77M |
Gross Profit | 2.56M | 5.65M | 9.45M |
EBITDA | -2.12M | 2.30M | 6.37M |
Net Income | -2.29M | 2.18M | 6.22M |
Balance Sheet | |||
Total Assets | 5.08M | 9.71M | 15.25M |
Cash, Cash Equivalents and Short-Term Investments | 2.10M | 5.16M | 6.19M |
Total Debt | 907.45K | 400.00K | 410.88K |
Total Liabilities | 1.91M | 910.27K | 1.24M |
Stockholders Equity | 3.17M | 8.80M | 14.01M |
Cash Flow | |||
Free Cash Flow | 494.19K | 6.51M | 8.94M |
Operating Cash Flow | 540.35K | 7.00M | 9.36M |
Investing Cash Flow | -46.17K | -490.02K | -422.49K |
Financing Cash Flow | -3.55M | -7.54M | -4.57M |
On July 24, 2025, Callan JMB Inc. entered into a Purchase Agreement with an investor, allowing the company to potentially sell up to $25 million of its common stock. The agreement provides Callan JMB with flexibility in raising capital, as it is not obligated to sell shares and can issue purchase notices based on market conditions. The company also entered a Registration Rights Agreement, requiring it to file a registration statement with the SEC. Failure to comply with these terms would result in the issuance of additional shares to the investor.